Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 3/20 | 0.37 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.37 |
| ▸ | BCHE | P06276 | 1/20 | 0.37 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.37 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.37 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21865727 | 0.91 | ACHE (0.39) | ACHESIGMAR1BCHEHRH3 | |
| SCHEMBL21801067 | 0.89 | S1PR1 (0.35) | ACHESIGMAR1BCHES1PR1S1PR3 | |
| SCHEMBL21801244 | 0.85 | ABCG2 (0.42) | SIGMAR1S1PR1S1PR3 | |
| SCHEMBL21801191 | 0.84 | CYSLTR1 (0.45) | SIGMAR1BCHES1PR1S1PR3 | |
| SCHEMBL21801081 | 0.84 | CYSLTR1 (0.45) | SIGMAR1BCHES1PR1S1PR3 | |
| SCHEMBL21801083 | 0.84 | CYSLTR1 (0.45) | SIGMAR1BCHES1PR1S1PR3 | |
| SCHEMBL21801077 | 0.84 | ABCB1 (0.38) | SIGMAR1BCHES1PR1S1PR3 | |
| SCHEMBL21801127 | 0.84 | ABCB1 (0.38) | SIGMAR1BCHES1PR1S1PR3 | |
| SCHEMBL21801151 | 0.83 | FFAR4 (0.39) | BCHES1PR1S1PR3 | |
| SCHEMBL21801085 | 0.82 | ALDH2 (0.41) | SIGMAR1S1PR1S1PR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020052774-A1 | FLAVONE DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS DISEASE | F. HOFFMANN-LA ROCHE AG (CH) | 2020-03-19 | — | — | WO | disclosed |